Toncev G - Search Results

1

Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis.

Toncev G. Toncev G. Vojnosanit Pregl. 2006 Oct;63(10):879-82. doi: 10.2298/vsp0610879t. Vojnosanit Pregl. 2006. PMID: 17121380 Clinical Trial.

2

Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.

Toncev G, Milicic B, Toncev S, Samardzic G. Toncev G, et al. Among authors: toncev s. Eur J Neurol. 2002 May;9(3):221-6. doi: 10.1046/j.1468-1331.2002.00384.x. Eur J Neurol. 2002. PMID: 11985629

3

Prevalence of multiple sclerosis in the Serbian district Sumadija.

Toncev G, Miletic Drakulic S, Knezevic Z, Boskovic Matic T, Gavrilovic A, Toncev S, Drulovic J, Pekmezovic T. Toncev G, et al. Among authors: toncev s. Neuroepidemiology. 2011;37(2):102-6. doi: 10.1159/000330836. Epub 2011 Sep 15. Neuroepidemiology. 2011. PMID: 21921643

4

Unusual case of stroke related to Kocuria Kristinae endocarditis treated with surgical procedure.

Aleksic D, Miletic-Drakulic S, Boskovic-Matic T, Simovic S, Toncev G. Aleksic D, et al. Among authors: toncev g. Hippokratia. 2016 Jul-Sep;20(3):231-234. Hippokratia. 2016. PMID: 29097891 Free PMC article.

5

Erratum to "Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome".

Tb M, G T, A G, D A. Tb M, et al. Among authors: g t. Open Med (Wars). 2020 Nov 27;16(1):23. doi: 10.1515/med-2021-0006. eCollection 2021. Open Med (Wars). 2020. PMID: 33364430 Free PMC article.

6

Potential Drug-drug Interactions in Acute Ischemic Stroke Patients at the Neurological Intensive Care Unit.

Aleksic DZ, Jankovic SM, Mlosavljevic MN, Toncev GL, Miletic Drakulic SD, Stefanovic SM. Aleksic DZ, et al. Among authors: toncev gl. Open Med (Wars). 2019 Nov 7;14:813-826. doi: 10.1515/med-2019-0093. eCollection 2019. Open Med (Wars). 2019. PMID: 31737786 Free PMC article.

7

Depression and Fatigue in Patients With Multiple Sclerosis Have No Influence on the Parameters of Cognitive Evoked Potentials.

Lazarevic S, Azanjac Arsic A, Aleksic D, Toncev G, Miletic-Drakulic S. Lazarevic S, et al. Among authors: toncev g. J Clin Neurophysiol. 2021 Jan 1;38(1):36-42. doi: 10.1097/WNP.0000000000000640. J Clin Neurophysiol. 2021. PMID: 31725033

8

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators. Cadavid D, et al. Lancet Neurol. 2019 Sep;18(9):845-856. doi: 10.1016/S1474-4422(19)30137-1. Epub 2019 Jul 5. Lancet Neurol. 2019. PMID: 31285147 Clinical Trial.

9

Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome.

Matić TB, Toncev G, Gavrilović A, Aleksić D. Matić TB, et al. Among authors: toncev g. Open Med (Wars). 2019 Jun 11;14:479-484. doi: 10.1515/med-2019-0051. eCollection 2019. Open Med (Wars). 2019. PMID: 31231684 Free PMC article.

10

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.

Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results